G. Carl Huber
- Topics
- Complement system in diseases (5 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Chronic Lymphocytic Leukemia Research (3 papers)
In The Last Decade
G. Carl Huber
23 papers receiving 571 citations
Peers
Comparison fields: 5 of 96
- Immunology 141
- Rehabilitation 104
- Molecular Biology 96
- Cell Biology 90
- Ecology 84
Countries citing papers authored by G. Carl Huber
This map shows the geographic impact of G. Carl Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Carl Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Carl Huber more than expected).
Fields of papers citing papers by G. Carl Huber
This network shows the impact of papers produced by G. Carl Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Carl Huber. The network helps show where G. Carl Huber may publish in the future.
Co-authorship network of co-authors of G. Carl Huber
This figure shows the co-authorship network connecting the top 25 collaborators of G. Carl Huber. A scholar is included among the top collaborators of G. Carl Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Carl Huber. G. Carl Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 61 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 26 | |
| 8 | 41 | |
| 9 | 12 | |
| 10 | 18 | |
| 11 | 45 | |
| 12 | 56 | |
| 13 | 10 | |
| 14 | 0 | |
| 15 | 98 | |
| 16 | 61 | |
| 17 | 90 | |
| 18 | HERZFREQUENZ UND STOFFWECHSELGROESSEN BEI LANGZEITAUTOFAHRTEN UNTER BETA-REZEPTORENBLOCKADE (BUNITROLOL) | 1 |
| 19 | Anaerobe Energiebereitstellung im Hochleistungssport : die Bedeutung der metabolischen Azidose unter physiologischen und pathologischen Bedingungen | 8 |
| 20 | [Effect of a new beta-receptor blockader (Bunitrolol) on the circulation and metabolism during extreme stress conditions]. | 4 |
About G. Carl Huber
G. Carl Huber is a scholar working on Rehabilitation, Virology and Immunology, having authored 25 papers that have together received 601 indexed citations. Recurring topics across this work include Complement system in diseases (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Rehabilitation (104 citations), Complementary and alternative medicine (66 citations) and Endocrinology (38 citations). G. Carl Huber has collaborated with scholars based in Germany, Austria and France. Frequent co-authors include Gerhard Haszprunar, M. Lehmann, M. Da Prada, J. Keul, E. Keck, Enno Logemann, L Rokitzki, Zoltán Bánki, Heribert Stoiber and Asim Ejaz. Their work appears in journals such as Journal of Neuroscience, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.